Vaxcyte Reports Second Quarter 2023 Financial Results and
-- Advanced Ongoing VAX-24 Phase 2 Infant Study to Second Stage, Dosing First New Participants in July 2023; Topline Data from Primary Immunization Series...
Jennifer Zibuda Janet Graesser Michaele Kamarck Advisory Committee On Immunization Practices University Of Maryland Sutro Biopharma Inc
Source: globenewswire.com